Blood test for early colorectal tumors
Part of Cancer, Digestive system clinical trials.
This trial studies a simple blood test to learn more about early colorectal tumors. It may help doctors understand these tumors better and could lead to better care in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a superficial (early) colorectal tumor and are scheduled for a procedure called submucosal dissection.
- You are already part of the FECCo cohort study and agree to also join the FECCo biobank.
- You are willing to have your blood collected for research.
- You do not have significant health problems that would make blood collection unsafe.
- You have not been diagnosed with distant metastasis (cancer that has spread to other organs).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether a blood test can help identify colorectal cancer or precancerous growths. You would have a planned colonoscopy, and researchers compare the blood test results to what the colonoscopy finds.
This study tests whether a simple blood test can track how well your colorectal cancer is responding to first-line chemotherapy. By monitoring cancer markers in your blood, doctors may be able to detect treatment changes earlier than traditional imaging.
This study is testing a new blood test to find colorectal cancer early. You may be able to join if you are about to have a colonoscopy or surgery for a suspected tumor.
This study looks at whether a simple blood test can help guide the care of people being evaluated for colorectal cancer. It may support earlier or clearer decision-making alongside existing screening or colonoscopy results.
This study tests a new blood test that might help detect colorectal cancer. If you're already planning a colonoscopy or colorectal surgery, your participation could help improve early detection.
This study uses a simple blood test to find early signs of colorectal cancer in people who already had a positive stool test. If it works, it could help avoid unnecessary colonoscopies in the future.
Hear when a new Precancerous Conditions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.